Answers are grounded in this paper and cite their sources.
We report that an organolithium addition to a chiral ketimine, which because of competitive proton transfer proceeds with only modest yield in batch, can be significantly improved in flow. The transformation was discovered to be highly mixing-sensitive but remarkably temperature-independent in flow, enabling the continuous process to be performed under noncryogenic conditions. Experiments at the kilogram scale provided robust operating conditions that are amenable to implementing this chemistry for the manufacture of verubecestat (MK-8931), a drug candidate for the treatment of Alzheimer’s disease.
No takes yet. Share an insight, caveat, or question.
Thaisrivongs et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: